A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases.
The best Bull and Bear pitches based on recency and number of recommendations.
The stock will outperform the market because of the FDA approval date set for Sept 1st, people are going to be pumping it up throughout August.
This is a risky red thumb, because in the current volatile biopharma environment almost any dubious outfit can become a multibagger in a fortnight if the right people suddenly take an interest in making it one. On the other hand, I think it's more… More
Read the most recent pitches from players about MSTX.
Recs
union9193
(< 20)
Submitted: 10/8/2014 8:27:46 PM :
Start Price:
$0.58
NYSE MKT:MSTX Score:
-168.78
Currently under valued.
Recs
asilverp
(< 20)
Submitted: 8/27/2014 11:55:58 PM :
Start Price:
$0.61
NYSE MKT:MSTX Score:
-166.58
I have to agree with Buffetjunior, it seems hard to argue with the risk/reward of a company with no debt, cash on hand, assets on the books and low share price in an industry that is potentially transformative.
Recs
DanishDynamite
(< 20)
Submitted: 7/22/2011 4:36:53 AM :
Start Price:
$3.58
NYSE MKT:MSTX Score:
-275.63
Build-up and spike on FDA decision
Find the members with the highest scoring picks in MSTX.
smallandmidcap (88.91) Score: +328.90
The Score Leader is the player with the highest score across all their picks in MSTX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| smallandmidcap | 88.91 | 8/10/2010 |
|
5Y | $2.03 | -93.55% | +235.36% | +328.90 | 0 Comment | |
| longtermgrowth09 | < 20 | 8/3/2010 |
|
5Y | $2.13 | -93.85% | +234.01% | +327.86 | 0 Comment | |
| decembermeter | 37.60 | 12/6/2010 |
|
5Y | $2.47 | -94.70% | +206.37% | +301.07 | 0 Comment | |
| brandonprice1973 | < 20 | 10/25/2011 |
|
5Y | $1.10 | -88.09% | +202.25% | +290.34 | 0 Comment | |
| 4x4ing | 65.25 | 10/19/2006 |
|
3W | $2.72 | -95.18% | +192.55% | +287.74 | 0 Comment | |
| 3acrerock | 71.29 | 1/3/2007 |
|
1Y | $2.84 | -95.39% | +178.69% | +274.08 | 0 Comment | |
| ramhigh | < 20 | 2/8/2007 |
|
3W | $2.50 | -94.76% | +175.11% | +269.87 | 0 Comment | |
| IdahoInvestor | 27.88 | 5/30/2012 |
|
5Y | $0.53 | -75.28% | +185.42% | +260.70 | 0 Comment | |
| crowke | < 20 | 6/29/2007 |
|
3M | $2.54 | -94.84% | +161.75% | +256.59 | 0 Comment | |
| ECWTully369 | < 20 | 9/17/2012 |
|
3M | $0.69 | -81.01% | +155.68% | +236.69 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
